Citation: | GENG Xiafei, LIU Shaoping, FANG Min, LI Yan. Quantum Dots-based Molecule Probe Double Immunofluorescence Techniques to Investigate Clonal Growth Behaviors of Cancer Cells[J]. Cancer Research on Prevention and Treatment, 2015, 42(02): 103-107. DOI: 10.3971/j.issn.1000-8578.2015.02.001 |
[1] |
Dowsett M, Nielsen TO, A’Hern R, et al. Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group[J]. J Natl Cancer Inst, 2011, 10 3(22): 1656-64.
|
[2] |
Huang SD, Liu XH, Bai CG, et al. Relationship between cancer stem cells and clone formation in A549 lung cancer cell lines[J]. Zhonghua Wai Ke Za Zhi, 2006, 23(9):1053-5. [黄盛东, 刘晓红, 白辰光, 等. A549肺癌细胞株中肿瘤干细胞与克隆形成的关系 [J] 中华外科杂志, 2006, 23(9): 1053-5.]
|
[3] |
Franken NA, Rodermond HM, Stap J, et al. Clonogenic assay of cells in vitro[J]. Nat Protoc, 2006, 1(5): 2315-9.
|
[4] |
Munshi A, Hobbs M, Meyn RE. Clonogenic cell survival assay[J]. Methods Mol Med, 2005, 110: 21-8.
|
[5] |
Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown[J]. J Cell Physiol, 2000, 182(3): 311-22.
|
[6] |
Weng KC, Nobel CO, Papahadjopolous-Sternberg B, et al. Targeted tumor cell internalization and imaging of multifunctional quantum dot-conjugated immunoposomes in vitro and in vivo[J]. Nano Lett, 2008, 8(9): 2851-7.
|
[7] |
Gokarna A, Jin LH, Hwang JS, et al. Quantum dot-based protein micro- and nanarrays for detection of prostate cancer biomarkers[J]. Proteomics, 2008, 8(9): 1809-18.
|
[8] |
Chen LD, Liu J, Yu XF, et al. The biocompatibility of quantum dot probes used for the targeted imaging of hepatocellular carcinoma metastasis[J]. Biomaterials, 2008, 29(31): 4170-6.
|
[9] |
Chen C, Xia HS, Gong YP, et al. The quantitative detection of total HER2 load by quantum dots and the identification of a new subtype of breast cancer with different 5-year prognosis[J]. Biomaterials, 2010, 31(33): 8818-25.
|
[10] |
Peng CW, Liu XL, Chen C, et al. Patterns of cancer invasion revealed by QDs-based quantitative multiplexed imaging of tumor microenvironment[J]. Biomaterials, 2011, 32(11): 2907-17.
|
[11] |
Zhang Y, Yuan SL, Jiang PF, et al. Contrast research using two cultural methods for breast cancer SK-BR-3 cell cloning experiment[J]. Shandong Yi Yao, 2010, 50(51): 29-30. [张迎, 袁 胜利, 姜鹏飞, 等.两种培养方法用于乳腺癌SK-BR-3细胞克隆 形成实验的对比研究[J]. 山东医药, 2010, 50(51): 29-30.]
|
[12] |
Li X, Pan Y, Fan R, et al. Adenovirus-delivered CIAPIN1 small interfering RNA inhibits HCC growth in vitro and in vivo[J]. Carcinogenesis, 2008, 29(8): 1587-93.
|
[13] |
Plumb JA. Cell sensitivity assays: clonogenic assay[J]. Methods Mol Med, 2004, 88(5): 159-64.
|
[14] |
Frangioni JV. New technologies for human cancer imaging[J]. J Clin Oncol, 2008, 26(24): 4012-21.
|
[15] |
Kim J, Piao Y, Hyeon T. Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy[J]. Chem Soc Rev, 2009, 38(2): 372-90.
|
[16] |
Hong H, Zhang Y, Sun J, et al. Molecular imaging and therapy of cancer with radiolabeled nanoparticles[J]. Nano Today, 2009, 4( 5): 399-413.
|
[17] |
Peng CW, Tian Q, Yang GF, et al. Quantum-dots based simultaneous detection of multiple biomarkers of tumor stromal features to predict clinical outcomes in gastric cancer[J]. Biomaterials, 2012, 33(23): 5742-52.
|
[18] |
Resch-Genger U, Grabolle M, Cavaliere-Jaricot S, et al. Quantum dots versus organic dyes as fluorescent labels[J]. Nat Methods, 20 08, 5(9): 763-75.
|
[19] |
Beresford MJ, Wilson GD, Makris A. Measuring proliferation in breast cancer: practicalities and applications[J]. Breast Cancer Res, 2006, 8(6): 216.
|
[20] |
Brabletz T, Jung A, Spaderna S, et al. Migrating cancer stem cellsan integrated concept of malignant tumour progression[J]. Nat Rev Cancer, 2005, 5(9): 744-749.
|
[21] |
Gong P, Wang Y, Liu G, et al. New insight into Ki67 expression at the invasive front in breast cancer[J]. PLoS One, 2013, 8(1): e54912.
|